Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nasdaq Pharmaceuticals ETF (FTXH)

Nasdaq Pharmaceuticals ETF (FTXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 17,001,900
  • Shares Outstanding, K 600
  • 60-Month Beta 0.70
  • Price/Earnings ttm 16.59
  • Annual Dividend & Yield 0.44 (1.56%)
  • Most Recent Dividend 0.122 on 09/26/24
  • Management Fee 0.60%
  • Sectors:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.96 +0.71%
on 10/25/24
29.00 -2.90%
on 10/16/24
-0.41 (-1.44%)
since 10/04/24
3-Month
27.60 +2.03%
on 08/07/24
29.72 -5.25%
on 08/29/24
-0.47 (-1.64%)
since 08/02/24
52-Week
23.85 +18.07%
on 11/10/23
29.72 -5.25%
on 08/29/24
+3.30 (+13.27%)
since 11/03/23

Most Recent Stories

More News
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson JNJ infused positive optimism for the broader healthcare sector after posting solid third-quarter 2024 earnings on Oct. 15. The world's biggest healthcare products maker continued with...

XLV : 146.83 (-0.62%)
JNJ : 158.48 (-1.03%)
IHE : 68.41 (-0.74%)
IYH : 62.10 (-0.50%)
PPH : 90.92 (-0.51%)
FTXH : 28.16 (-0.62%)
Do Wall Street Analysts Like Gilead Sciences Stock?

Gilead Sciences has underperformed the broader market over the past year, yet Wall Street analysts remain moderately bullish about the stock’s prospects.

GILD : 89.92 (+0.46%)
$SPX : 5,723.10 (-0.10%)
FTXH : 28.16 (-0.62%)
Bristol-Myers Squibb Stock: Analyst Estimates & Ratings

Bristol-Myers Squibb has underperformed the market over the past year, and Wall Street analysts remain cautious about the stock prospects.

BMY : 55.17 (+1.56%)
$SPX : 5,723.10 (-0.10%)
FTXH : 28.16 (-0.62%)
MS : 116.53 (-0.27%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFDI : 64.71 (+0.27%)
RFEM : 65.29 (+0.42%)
RFEU : 63.88 (+0.52%)
FTSL : 46.03 (+0.11%)
FTSM : 59.81 (+0.02%)
HISF : 44.26 (+0.18%)
HYLS : 41.51 (+0.27%)
LMBS : 48.63 (+0.16%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFDI : 64.71 (+0.27%)
RFEM : 65.29 (+0.42%)
RFEU : 63.88 (+0.52%)
FCVT : 35.98 (+0.78%)
FTSL : 46.03 (+0.11%)
HISF : 44.26 (+0.18%)
HYLS : 41.51 (+0.27%)
LMBS : 48.63 (+0.16%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFDI : 64.71 (+0.27%)
RFEM : 65.29 (+0.42%)
RFEU : 63.88 (+0.52%)
FCVT : 35.98 (+0.78%)
FTSL : 46.03 (+0.11%)
HISF : 44.26 (+0.18%)
HYLS : 41.51 (+0.27%)
LMBS : 48.63 (+0.16%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFDI : 64.71 (+0.27%)
RFEU : 63.88 (+0.52%)
FCVT : 35.98 (+0.78%)
FTSL : 46.03 (+0.11%)
HISF : 44.26 (+0.18%)
HYLS : 41.51 (+0.27%)
LMBS : 48.63 (+0.16%)
FTHI : 22.96 (+0.04%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFDI : 64.71 (+0.27%)
RFEM : 65.29 (+0.42%)
RFEU : 63.88 (+0.52%)
FCVT : 35.98 (+0.78%)
FDIV : 28.35 (+0.09%)
FTSL : 46.03 (+0.11%)
FTSM : 59.81 (+0.02%)
HYLS : 41.51 (+0.27%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFDI : 64.71 (+0.27%)
RFEM : 65.29 (+0.42%)
RFEU : 63.88 (+0.52%)
FCVT : 35.98 (+0.78%)
FDIV : 28.35 (+0.09%)
FTSL : 46.03 (+0.11%)
HYLS : 41.51 (+0.27%)
LMBS : 48.63 (+0.16%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded funds (each a “Fund,” collectively, the “Funds”) advised by FTA.

FCAL : 49.72 (+0.22%)
FEMB : 27.37 (+0.54%)
FMB : 51.31 (+0.36%)
FMHI : 48.77 (+0.41%)
RFAP : 58.36 (+1.32%)
RFDI : 64.71 (+0.27%)
RFEM : 65.29 (+0.42%)
RFEU : 63.88 (+0.52%)
FCVT : 35.98 (+0.78%)
FDIV : 28.35 (+0.09%)
FTSL : 46.03 (+0.11%)
HYLS : 41.51 (+0.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks...

See More

Key Turning Points

3rd Resistance Point 28.41
2nd Resistance Point 28.39
1st Resistance Point 28.37
Last Price 28.16
1st Support Level 28.32
2nd Support Level 28.31
3rd Support Level 28.28

See More

52-Week High 29.72
Last Price 28.16
Fibonacci 61.8% 27.48
Fibonacci 50% 26.78
Fibonacci 38.2% 26.09
52-Week Low 23.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar